The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 16, Issue 2, 2004, Pages 199-211

  Ingersoll, K ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANXIETY NEUROSIS; COCAINE DEPENDENCE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG PREFERENCE; FEMALE; HEROIN DEPENDENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL INSTABILITY; PATIENT CARE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK FACTOR; SOCIAL PHOBIA; SUBSTANCE ABUSE;

ANTIVIRAL AGENTS; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT REFUSAL;

EID: 0842265854     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120410001641048     Document Type: Review

References (21)

1. AMERICAN PSYCHIATRIC ASSOCIATION (2000). Diagnostic and statistical manual of mental disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
2. BABOR, T.F., DE LA FUENTE, J.R., SAUNDERS, J. & GRANT, M. (1992). The alcohol use disorders identification test: guidelines for use in primary health care. Unpublished manual: World Health Organization.
3. BOHN, M.J., BABOR, T.F. & KRANZLER, H.R. (1995). The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. Journal of Studies on Alcohol, 56, 423-432.
4. BRESLIN, F.C., SOBELL, L.C., SOBELL, M.B. & AGRAWAL, S. (2000). A comparison of a brief and long version of the Situational Confidence Questionnaire. Behaviour Research and Therapy, 38, 1211-1230.
5. CATZ, S.L., KELLY, J.A., BOGART, L.M., BENOTSCH, E.G. & MCAULIFFE, T.L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
6. COOK, R.L., SERELKA, S.M., HUNT, S.C., WOODWARD, W.C., ERLEN, J.A. & CONIGLIARO, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83-88.
7. DEAN, L.M. & KING, E.S. (1999). Promoting medication adherence in HIV treatment. Nursing Spectrum, January, 12-14.
8. DEMASI, R.A., GRAHAM, N.M., TOLSON, J.M., PHAM, S.V., CAPUANO, G.A., FISHER, R.L., SHAEFER, M.S., PAKES, G.E., SAWYER, G.A. & ERON, J.J. (2001). Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virulogic outcome. Advances in Therapeutics, 18, 163-173.
9. DUNBAR-JACOB, J. (2002). Adherence: perspective on the individual. Master Lecture, Society of Behavioral Medicine 23rd Annual Meeting and Scientific Sessions, 3-6 April 2002, Washington, DC.
10. GROSS, R., BILKER, W.B., FRIEDMAN, H.M. & STROM, B.L. (2001). Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS, 9, 2109-2117.
11. INGERSOLL, K.S. (1999). The Medication Adherence Form (MAF). Unpublished test. Richmond, VA: Virginia Commonwealth University.
12. KESSLER, R.C., ANDREWS, G. MROCZEK, D., USTUN, B. & WITTCHEN, H. (1998). The World Health Organization Composite International Diagnostic Interview Short Form (CIDI-SF). International Journal of Methods in Psychiatric Research, 7, 171-185.
13. LUCAS, G.M., GOBO, K.A., CHAISSON, R.E. & MOORE, R.D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 29, 767-774.
14. NATIONAL INSTITUTE ON DRUG ABUSE (1993). Drug History Form. In How good is your drug abuse treatment program? Resource manual. Rockville, MD: NIDA, RS3-40-RS3-41.
15. RESEARCH TRIANGLE INSTITUTE. (1997). The HIV/AIDS Mental Health Services Program: Final Report. Research Triangle Park, NC: RTI.
16. SINGH, N., SQUIER, C., SIVEK, C., WAGENER, M., HONG NGUYEN, M. & YU, V.L. (1996). Determinants of compliance with antiretroviral therapy in patients with HIV: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
17. STONE, V.E., WEISSMAN, J.S. & CLEARY, P.D. (1995). Satisfaction with ambulatory care of persons with AIDS: predictors of patient ratings of quality. Journal of General Internal Medicine, 10, 239-245.
18. THE MEASUREMENT GROUP. (1997). Module P1: adherence to therapy interview. Retrieved from: www.themeasurementgroup.com/resource/protease_int.htm.
19. TURNER, B.J., FLEISHMAN, J.A., WENGER, N., LONDON, A.S., BURNAM, M.A., SHAPIRO, M.F., BING, E.G., STEIN, M.D., LONGSHORE, D. & BOZZETTE, S.A. (2001). Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625-633.
20. WORLD HEALTH ORGANIZATION WHO. (1998). The WHO CIDI-SF, v1.0, November 1998. Retrieved from: www.who.int/msa/cidi/cidisf.htm.
21. WUTOH, A.K., BROWN, C.M., KUMOJI, E.K., DAFTARY, M.S., JONES, T., BARNES, N.A. & POWELL, N.J. (2001). Antiretroviral adherence and use of alternative therapies among older HIV-infected adults. Journal of the National Medical Association, 93, 243-250.